Hepatic IL-24 mRNA levels were downregulated in NAFLD patients compared to controls (P < 0.0001; Fig. 1D), which was further supported by qPCR analysis in the HFFD-induced mouse model of NAFLD (Fig. 1E). This evidence concerns the gene IL24 and metabolic dysfunction-associated steatotic liver disease.